One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine

BACKGROUND: A third dose of the BNT162b2 SARS-CoV-2 vaccine leads to a significant increase in antibody levels, however, concerns regarding the long-term persistence of this response exist. We assessed the humoral response for one year following vaccination. METHODS: A prospective study among immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wand, Ori, Breslavsky, Anna, Bar-Shai, Amir, Levy, Chezy, Maayan, Shlomo, Rimler, Avi, Zwahra, Moatasem, Cohen-Hagai, Keren, Harish, Alma, Zacks, Nadav, Bilenko, Natalya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767891/
https://www.ncbi.nlm.nih.gov/pubmed/36566162
http://dx.doi.org/10.1016/j.vaccine.2022.12.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767891/
https://www.ncbi.nlm.nih.gov/pubmed/36566162
http://dx.doi.org/10.1016/j.vaccine.2022.12.042

Ejemplares similares